The big question
Could dinosaurs hold the key to solving human respiratory problems?
Research
Ground Zero
Workers suffer long-term health effects five years after World Trade Center terrorist attacks.
Drug trials
Small and medium-size contract research organisations (CROs) have huge potential. For the last few decades, pharmaceutical companies have increasingly chosen to use medium-size contract research organisations (CROs), or smaller organisations, rather than the larger organisations, due to their enhanced responsiveness and flexibility, that provides good geographic coverage, a broad therapeutic…
The Spanish National Centre for Cardiovascular Research
The objective of the CNIC is to lead cardiovascular research in Spain and establish itself as a leading international centre.
Student's immune defences hit by examination nerves
Researchers found out important links between mental stress and characteristic complex physical inflammation reactions of allergies.
Pulmotension
EU multidisciplinary lung research project aims to cure pulmonary hypertension.
Drug, vaccine and surgery
Obesity is a burgeoning nightmare for everyone involved in healthcare delivery. New treatment possibilities can help to solve this probelm.
Tobacco
Previous studies have shown that tobacco smoking increases the risk ...
An all-out attack on auto-immune disease
The foundation of the AESKU.KIPP Institute, based in Wendelsheim, Germany, presents a platform to initiate and co-ordinate international auto-immunity research projects.
The European Institute of Molecular Imaging
The First European Institute of Molecular Imaging (EIMI) was foundet at the Westphalian Wilhelms-University in Muenster, Germany.
Here - and the far horizons
Dr Hanns-Joachim Weinmann, Diagnostics and Radiopharmaceuticals, Magnetic Resonance Imaging & X-Ray Research, Schering AG, examines what is feasible and what still lies only at a tantalising distance.
Health technology assessments
An unnecessary rein on medical innovations, or a wise insurance for patients' protection?
Aging and death
A medical failure or biological necessity?
The advent of personalised therapies
12 distinguished researchers and industry representatives presented the latest molecular medicine research at the Molecular Medicine - from Diagnostics to Therapy symposium - one in a series of annual diagnostics seminars organised by the Forum Medicine Technology & Pharmaceutics e.V.
Defying physics
Dr Robert Krieg, Director of MR Molecular Imaging at Siemens Medical Solutions, described, in an interview with Daniela Zimmermann of European Hospital, the limitations of physics and the potential clinical benefits of hybrid technology - and a hitherto hush-hush MRI-PET project
Todays treatments
Dr Christiane Eickelberg, of the University of Giessen Lung Centre (UGLC), outlines the centre's research projects, aims and academic offerings
Pandemic panic sends feathers flying
AIDS, SARS and now H5NI; just a brief beginning or the end? As the virus moves towards Europe, and millions of birds are slaughtered, interest has risen in a Chinese herb, a patent-sharing controversy and drug stockpiling
Intergroup Exemestane Study (IES) results
Currently, five years of treatment with tamoxifen is considered the 'gold-standard' treatment for postmenopausal women with breast cancer. This drug blocks oestrogen, which can help fuel the growth of tumours in some cases.
Clinical immunology
The fundamental role of inflammation in almost all disease processes has been increasingly recognised over several years.
Bone marrow cells given gene therapy 'shield'
Radiotherapy affects bone marrow cells, lowering production of white blood cells. New research, published in The Journal of Gene Medicine, suggests that pre-treatment with a gene therapy 'shield' could defend healthy bone marrow cells.
Paper handkerchief technology
The Europe-wide research by Westminster University, England and T.Ü.V. Rhineland, Germany, has proved the advantages of hand wiping with paper rather than with textiles or warm air.
Liberal drugs policy works
Switzerland - Providing heroin addicts methadone or buprenorphine as a treatment for their addiction has led to a decline in the number of new heroin users in Zurich, according to a paper by Carlos Nordt and Rudolf Stohler from the Psychiatric University Hospital, Zurich, published in The Lancet.
Article • In vitro fertilisation
Watch out for IVF identity fraud
Hospitals and fertility clinics across Europe are to be warned that safeguards must be implemented to prevent impostors gaining access to IVF treatment.
